x

try the demo

Your privacy is our priority.
For more information, please read our privacy policy.

Active Trading Blog

2 Signs Things Could Get Much Worse For NVIDIA Before They Get Better

By: Wayne Duggan Since the beginning of 2015, NVIDIA Corporation (NASDAQ: NVDA) has been the hottest stock in the entire S&P 500. NVIDIA shares are up more than 410 percent over the last two years, but the tech darling may have recently lost its mojo. After peaking at an all-time high of $119.93 in December,.. Read more

The IPOX® Week, January 16, 2017

Most IPOX Indexes extend YTD gains. IPOX Global and IPOX Europe surpass markets. Political/Legal overhang pressure select IPOX holdings. Ahead of U.S. deal flow, H.K. IPOs debut strongly. Most IPOX Indexes extend YTD gains. IPOX Global and IPOX Europe surpass markets. Most IPOX Indexes extended the YTD gains into the second week of trading in.. Read more

Option Straddles Can Take The Guess Work Out Of Earnings Season

By: Wayne Duggan With Q4 earnings season just around the quarter, a number of companies will be reporting critical holiday sales numbers that will set the tone for 2017 and beyond. With so much at stake this earnings season, there will certainly be some violent earnings-related moves in the stock market. Unfortunately, as traders know.. Read more

The IPOX® Week, January 09, 2017

IPOX Indexes start year with big gains. IPOX Global and IPOX U.S. surpass surging market benchmarks. IPOX-linked investment products focus: AUMs rise. New IPO window opens with slew of H.K. deals. IPOX Indexes start year with strong gains. IPOX Global and IPOX U.S. surpass rising markets. The IPOX Indexes started the year with big gains.. Read more

The IPOX® Week, December 31, 2016

In 2016, IPOX 100 U.S. ties Nasdaq 100. European IPOs record strong back-to-back gains vs. markets. Select IPOX-linked investment products rise strongly. Big year seen for IPOs and Spin-offs. In 2016, IPOX 100 U.S. ties Nasdaq 100. European IPOs record strong back-to-back gains vs. markets. The IPOX Indexes ended the year mixed with the IPOX.. Read more

Check the background of this firm on FINRA's BrokerCheck